Drug Type Therapeutic vaccine |
Synonyms Autologous Gp96 vaccine Cure Sure Biotech, Autologous heat shock protein Gp96 vaccine Cure Sure Biotech, Autologous tumour derived HSP Gp96 vaccine Cure Sure Biotech + [2] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Phase 2 | China | 09 Aug 2019 | |
Advanced gastric carcinoma | Phase 2 | China | 01 Nov 2014 | |
Stomach Cancer | Phase 2 | China | 28 Oct 2014 | |
Liver Cancer | Phase 2 | China | 01 Mar 2012 | |
Pancreatic adenocarcinoma | Phase 2 | China | 01 Mar 2012 | |
Pancreatic Cancer | Phase 2 | China | 22 Feb 2012 |
Phase 2 | Stomach Cancer Adjuvant | - | jrvxlwppcv(oxrylmfvvg) = no Gp96-related serious adverse event has been observed kpizdyzsig (lqsbhbllbn ) View more | Positive | 21 Mar 2017 | ||
Chemotherapy alone |